News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
253,442 Results
Type
Article (14031)
Company Profile (24)
Press Release (239382)
Multimedia
Podcasts (24)
Webinars (3)
Section
Business (71690)
Career Advice (1125)
Deals (14534)
Drug Delivery (54)
Drug Development (34717)
Employer Resources (47)
FDA (6688)
Job Trends (5834)
News (125967)
Policy (10371)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (782)
Accelerated approval (21)
Adcomms (7)
Allergies (88)
Alliances (11304)
ALS (109)
Alzheimer's disease (726)
Antibody-drug conjugate (ADC) (231)
Approvals (7065)
Artificial intelligence (317)
Autoimmune disease (132)
Automation (25)
Bankruptcy (111)
Best Places to Work (4938)
BIOSECURE Act (4)
Biosimilars (133)
Biotechnology (22)
Bladder cancer (146)
Brain cancer (40)
Breast cancer (464)
Cancer (3381)
Cardiovascular disease (280)
Career advice (903)
Career pathing (13)
CAR-T (151)
CDC (13)
Cell therapy (416)
Cervical cancer (29)
Clinical research (32592)
Collaboration (1029)
Compensation (572)
Complete response letters (24)
COVID-19 (1059)
CRISPR (50)
C-suite (393)
Cystic fibrosis (67)
Data (4718)
Decentralized trials (1)
Depression (98)
Dermatology (41)
Diabetes (308)
Diagnostics (2559)
Digital health (20)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (158)
Drug pricing (76)
Drug shortages (12)
Duchenne muscular dystrophy (164)
Earnings (54260)
Editorial (22)
Employer branding (10)
Employer resources (44)
Events (36754)
Executive appointments (476)
FDA (8764)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (934)
Gene editing (116)
Generative AI (23)
Gene therapy (350)
GLP-1 (642)
Government (1612)
Grass and pollen (5)
Guidances (365)
Healthcare (6890)
HIV (48)
Huntington's disease (26)
IgA nephropathy (60)
Immunology and inflammation (149)
Immuno-oncology (48)
Indications (98)
Infectious disease (1256)
Inflammatory bowel disease (92)
Inflation Reduction Act (6)
Influenza (95)
Intellectual property (108)
Interviews (198)
IPO (8537)
IRA (11)
Job creations (1191)
Job search strategy (775)
JPM (34)
Kidney cancer (15)
Labor market (46)
Layoffs (207)
Leadership (15)
Legal (2119)
Liver cancer (56)
Longevity (9)
Lung cancer (494)
Lymphoma (298)
Machine learning (29)
Management (11)
Manufacturing (418)
MASH (105)
Medical device (5114)
Medtech (5154)
Mergers & acquisitions (6702)
Metabolic disorders (849)
mRNA (73)
Multiple sclerosis (105)
NASH (11)
Neurodegenerative disease (222)
Neuropsychiatric disorders (67)
Neuroscience (1525)
NextGen: Class of 2026 (2073)
Non-profit (1550)
Now hiring (36)
Obesity (428)
Opinion (85)
Ovarian cancer (104)
Pain (122)
Pancreatic cancer (136)
Parkinson's disease (199)
Partnered (12)
Patents (214)
Patient recruitment (265)
Peanut (34)
People (9243)
Pharmaceutical (12)
Pharmacy benefit managers (11)
Phase 1 (8798)
Phase 2 (14058)
Phase 3 (12456)
Pipeline (4990)
Policy (73)
Postmarket research (1211)
Preclinical (3017)
Press Release (15)
Prostate cancer (188)
Psychedelics (25)
Radiopharmaceuticals (129)
Rare diseases (557)
Real estate (1352)
Recruiting (20)
Regulatory (9164)
Reports (26)
Research institute (826)
Resumes & cover letters (209)
Rett syndrome (28)
RNA editing (6)
RSV (59)
Schizophrenia (103)
Series A (142)
Series B (110)
Service/supplier (3)
Sickle cell disease (57)
Special edition (12)
Spinal muscular atrophy (94)
Sponsored (15)
Startups (1158)
State (1)
Stomach cancer (7)
Supply chain (60)
Tariffs (30)
The Weekly (23)
Vaccines (530)
Venture capital (51)
Weight loss (294)
Women's health (54)
Worklife (10)
Date
Today (47)
Last 7 days (397)
Last 30 days (1652)
Last 365 days (17869)
2026 (4516)
2025 (18208)
2024 (16899)
2023 (16187)
2022 (20646)
2021 (20272)
2020 (19028)
2019 (16794)
2018 (12749)
2017 (11970)
2016 (10566)
2015 (12717)
2014 (9228)
2013 (7262)
2012 (7941)
2011 (8061)
2010 (7267)
Location
Africa (322)
Alabama (30)
Alaska (2)
Arizona (97)
Arkansas (6)
Asia (16319)
Australia (2493)
California (7148)
Canada (1927)
China (721)
Colorado (284)
Connecticut (361)
Delaware (262)
Europe (36553)
Florida (875)
Georgia (190)
Hawaii (3)
Idaho (19)
Illinois (552)
India (38)
Indiana (308)
Iowa (11)
Japan (364)
Kansas (57)
Kentucky (18)
Louisiana (23)
Maine (49)
Maryland (737)
Massachusetts (5038)
Michigan (132)
Minnesota (316)
Mississippi (5)
Missouri (81)
Montana (9)
Nebraska (8)
Nevada (77)
New Hampshire (34)
New Jersey (2067)
New Mexico (9)
New York (1776)
North Carolina (762)
North Dakota (3)
Northern California (3573)
Ohio (161)
Oklahoma (7)
Oregon (13)
Pennsylvania (1220)
Puerto Rico (12)
Rhode Island (19)
South America (475)
South Carolina (22)
Southern California (2760)
Tennessee (95)
Texas (1128)
United States (24259)
Utah (153)
Virginia (170)
Washington D.C. (33)
Washington State (618)
West Virginia (3)
Wisconsin (105)
Wyoming (2)
253,442 Results for "5".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
COSCIENS Provides Strategic Update - March 5, 2026
March 5, 2026
·
4 min read
Press Releases
Outlook Therapeutics Announces Closing of $5.0 Million Public Offering
March 26, 2026
·
5 min read
Press Releases
Outlook Therapeutics Announces Pricing of $5.0 Million Public Offering
March 24, 2026
·
5 min read
Cancer
5 Therapies Moving the Multiple Myeloma Space Forward
A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told
BioSpace
. Here are five therapies that could change the treatment paradigm.
March 9, 2026
·
8 min read
·
Tristan Manalac
Press Releases
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split
March 23, 2026
·
5 min read
Press Releases
Regeneron Announces Investor Conference Presentation - March 5, 2026
March 5, 2026
·
1 min read
Mergers & acquisitions
Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy
In addition to delivering two approved medicines to Biogen’s portfolio, the acquisition of Apellis Pharmaceuticals will support the future launch of the pharma’s own kidney disease asset, currently in multiple Phase 3 trials.
March 31, 2026
·
4 min read
·
Annalee Armstrong
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
With more than $1.5 billion on the line, Gilead looks to bolster its CAR T portfolio.
October 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Carecubes Closes $6.5 Million Series A to Transform Infectious Disease Response
March 19, 2026
·
5 min read
Press Releases
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
March 24, 2026
·
3 min read
1 of 25,345
Next
